Featuring an interview with Dr Courtney D DiNardo on recent data
on the management of acute myeloid leukemia not eligible for
intensive induction therapy, including the following topics:
Management of Acute Myeloid Leukemia in Patients Not Eligible
for Intensive Induction Therapy — Courtney D DiNardo, MD, MSCE
(00:00)
Case: A woman in her mid-70s with AML and
diploid cytogenetics with mutations in NPM1, IDH1 and FLT3-TKD who
receives venetoclax with a hypomethylating agent (21:20)
Case: A man in his late 60s with AML with
del(5q), del(7q) and mutations in RUNX1 and SRSF2 (28:57)
Case: A woman in her late 60s with
relapsed/refractory AML with intermediate-risk cytogenetics
(35:22)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.